The WACC of Catalyst Pharmaceuticals Inc (CPRX) is 6.6%.
| Range | Selected | |
| Cost of equity | 7.30% - 12.20% | 9.75% |
| Tax rate | 22.90% - 24.70% | 23.80% |
| Cost of debt | 4.50% - 4.50% | 4.50% |
| WACC | 5.4% - 7.8% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.74 | 1.3 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.30% | 12.20% |
| Tax rate | 22.90% | 24.70% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 4.50% | 4.50% |
| After-tax WACC | 5.4% | 7.8% |
| Selected WACC | 6.6% | |